Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017, Article ID 1298263, 8 pages
https://doi.org/10.1155/2017/1298263
Research Article

Protective Effect of Daikenchuto on Dextran Sulfate Sodium-Induced Colitis in Mice

1Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami Kogushi, Ube, Yamaguchi 755-8505, Japan
2Yamaguchi University Health Administration Center, 1677-1 Yoshida, Yamaguchi, Yamaguchi 753-8511, Japan
3Center of Research and Education for Regenerative Medicine, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami Kogushi, Ube, Yamaguchi 755-8505, Japan
4Department of Laboratory Science, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami Kogushi, Ube, Yamaguchi 755-8505, Japan

Correspondence should be addressed to Shinichi Hashimoto; pj.ca.u-ihcugamay@333-sah

Received 7 September 2016; Revised 13 November 2016; Accepted 22 November 2016; Published 22 January 2017

Academic Editor: Jean-Francois Beaulieu

Copyright © 2017 Takaharu Matsunaga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. K. Podolsky, “Inflammatory bowel disease,” The New England Journal of Medicine, vol. 347, no. 6, pp. 417–429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. H. S. P. De Souza and C. Fiocchi, “Immunopathogenesis of IBD: current state of the art,” Nature Reviews Gastroenterology and Hepatology, vol. 13, no. 1, pp. 13–27, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Fellermann, D. Ludwig, M. Stahl, T. David-Walek, and E. F. Stange, “Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506),” The American Journal of Gastroenterology, vol. 93, no. 10, pp. 1860–1866, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Rutgeerts, W. J. Sandborn, B. G. Feagan et al., “Infliximab for induction and maintenance therapy for ulcerative colitis,” The New England Journal of Medicine, vol. 353, no. 23, pp. 2462–2476, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Reinisch, W. J. Sandborn, D. W. Hommes et al., “Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial,” Gut, vol. 60, no. 6, pp. 780–787, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. N. Ananthakrishnan, E. L. McGinley, and D. G. Binion, “Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations,” Inflammatory Bowel Diseases, vol. 15, no. 2, pp. 182–189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Endo, T. Nishida, K. Nishikawa et al., “Dai-kenchu-to, a Chinese herbal medicine, improves stasis of patients with total gastrectomy and jejunal pouch interposition,” American Journal of Surgery, vol. 192, no. 1, pp. 9–13, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Itoh, J. Yamakawa, M. Mai, N. Yamaguchi, and T. Kanda, “The effect of the herbal medicine dai-kenchu-to on post-operative ileus,” Journal of International Medical Research, vol. 30, no. 4, pp. 428–432, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Iwai, Y. Kume, O. Kimura, S. Ono, S. Aoi, and T. Tsuda, “Effects of herbal medicine Dai-Kenchu-To on anorectal function in children with severe constipation,” European Journal of Pediatric Surgery, vol. 17, no. 2, pp. 115–118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Kono, A. Kaneko, Y. Hira et al., “Anti-colitis and -adhesion effects of daikenchuto via endogenous adrenomedullin enhancement in Crohn's disease mouse model,” Journal of Crohn's and Colitis, vol. 4, no. 2, pp. 161–170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya, “A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice,” Gastroenterology, vol. 98, no. 3, pp. 694–702, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. C. G. Whittem, A. D. Williams, and C. S. Williams, “Murine colitis modeling using Dextran Sulfate Sodium (DSS),” Journal of Visualized Experiments, no. 35, 2010. View at Publisher · View at Google Scholar
  13. T. Karuppuchamy, E. H. Behrens, P. González-Cabrera et al., “Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease,” Mucosal Immunology, 2016. View at Publisher · View at Google Scholar
  14. H. Kim, N. Banerjee, R. C. Barnes et al., “Mango polyphenolics reduce inflammation in intestinal colitis-involvement of the miR-126/PI3K/AKT/mTOR axis in vitro and in vivo,” Molecular Carcinogenesis, vol. 56, no. 1, pp. 197–207, 2016. View at Publisher · View at Google Scholar
  15. Y. Morohoshi, K. Matsuoka, H. Chinen et al., “Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis,” Journal of Gastroenterology, vol. 41, no. 4, pp. 318–324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. M. T. Case, J. Knox Smith, and R. A. Nelson, “Acute mouse and chronic dog toxicity studies of danthron, dioctyl sodium sulfosuccinate, poloxalkol and combinations,” Drug and Chemical Toxicology, vol. 1, no. 1, pp. 89–101, 1978. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Kitamura, K. Kangawa, M. Kawamoto et al., “Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma,” Biochemical and Biophysical Research Communications, vol. 192, no. 2, pp. 553–560, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Wu, M. Zhou, and P. Wang, “Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-α in macrophage cell line and rat Kupffer cells,” Regulatory Peptides, vol. 112, no. 1–3, pp. 19–26, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. W. J. Sandborn, “Clinical perspectives in Crohn's disease. Moving forward with anti-TNF-α therapy: current needs and future treatments,” Reviews in gastroenterological disorders, vol. 7, pp. S23–35, 2007. View at Google Scholar · View at Scopus
  20. E. Gonzalez-Rey, A. Fernandez-Martin, A. Chorny, and M. Delgado, “Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease,” Gut, vol. 55, no. 6, pp. 824–832, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Talero, S. Sánchez-Fidalgo, C. A. de la Lastra, M. Illanes, J. R. Calvo, and V. Motilva, “Acute and chronic responses associated with adrenomedullin administration in experimental colitis,” Peptides, vol. 29, no. 11, pp. 2001–2012, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Hayashi, K. Narumi, S. Tsuji et al., “Impact of adrenomedullin on dextran sulfate sodium-induced inflammatory colitis in mice: insights from in vitro and in vivo experimental studies,” International Journal of Colorectal Disease, vol. 26, no. 11, pp. 1453–1462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Eto, K. Kitamura, and J. Kato, “Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases,” Clinical and Experimental Pharmacology and Physiology, vol. 26, no. 5-6, pp. 371–380, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Meeran, D. O'Shea, P. D. Upton et al., “Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study,” The Journal of Clinical Endocrinology & Metabolism, vol. 82, no. 1, pp. 95–100, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Westphal, M. Booke, and A. T. Dinh-Xuan, “Adrenomedullin: a smart road from pheochromocytoma to treatment of pulmonary hypertension,” European Respiratory Journal, vol. 24, no. 4, pp. 518–520, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Tan, W. Yu, Z. Lin et al., “Anti-inflammatory effect of ginsenoside Rb1 contributes to the recovery of gastrointestinal motility in the rat model of postoperative ileus,” Biological and Pharmaceutical Bulletin, vol. 37, no. 11, pp. 1788–1794, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Park, D. Oh, M. G. Lee, C. E. Lee, and Y. Kim, “6-Shogaol, an active compound of ginger, alleviates allergic dermatitis-like skin lesions via cytokine inhibition by activating the Nrf2 pathway,” Toxicology and Applied Pharmacology, vol. 310, pp. 51–59, 2016. View at Publisher · View at Google Scholar